Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
Subscribe To Our Newsletter & Stay Updated
